Log in

NASDAQ:CMECME Group Stock Price, Forecast & News

$164.59
-0.94 (-0.57 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$164.03
Now: $164.59
$166.89
50-Day Range
$162.01
MA: $175.75
$192.14
52-Week Range
$131.80
Now: $164.59
$225.36
Volume1.96 million shs
Average Volume2.08 million shs
Market Capitalization$59.02 billion
P/E Ratio24.71
Dividend Yield2.05%
Beta0.3
CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products. The company executes trade through its electronic trading platforms, open outcry, and privately negotiated transactions; and provides clearing for exchange-traded contracts and cleared swaps, as well as settlement services. It also offers transaction lifecycle management services, such as trade and portfolio management, financial resource optimization, analytics, and regulatory reporting. In addition, the company provides a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Read More
CME Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.4Dividend Strength: 3.3Insider Behavior: 4.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.57 out of 5 stars


Industry, Sector and Symbol

Industry Security & commodity brokers, dealers, exchanges & services
Sub-IndustrySpecialized Finance
SectorFinance
Current SymbolNASDAQ:CME
CUSIP12572Q10
Phone312-930-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.87 billion
Cash Flow$8.09 per share
Book Value$73.18 per share

Profitability

Net Income$2.12 billion

Miscellaneous

Employees4,360
Market Cap$59.02 billion
Next Earnings Date7/29/2020 (Confirmed)
OptionableOptionable

Receive CME News and Ratings via Email

Sign-up to receive the latest news and ratings for CME and its competitors with MarketBeat's FREE daily newsletter.

CME Group (NASDAQ:CME) Frequently Asked Questions

How has CME Group's stock been impacted by COVID-19 (Coronavirus)?

CME Group's stock was trading at $194.6750 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CME shares have decreased by 15.5% and is now trading at $164.59. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of CME Group?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 3 sell ratings, 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for CME Group.

When is CME Group's next earnings date?

CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for CME Group.

How can I listen to CME Group's earnings call?

CME Group will be holding an earnings conference call on Wednesday, July 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were CME Group's earnings last quarter?

CME Group Inc (NASDAQ:CME) issued its quarterly earnings data on Wednesday, April, 29th. The financial services provider reported $2.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.23 by $0.10. The financial services provider had revenue of $1.52 billion for the quarter, compared to analysts' expectations of $1.48 billion. CME Group had a return on equity of 10.15% and a net margin of 45.79%. The business's revenue was up 29.0% compared to the same quarter last year. During the same period last year, the firm posted $1.62 EPS. View CME Group's earnings history.

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group declared a quarterly dividend on Wednesday, May 6th. Stockholders of record on Wednesday, June 10th will be paid a dividend of $0.85 per share on Thursday, June 25th. This represents a $3.40 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date of this dividend is Tuesday, June 9th. View CME Group's dividend history.

What price target have analysts set for CME?

16 Wall Street analysts have issued twelve-month target prices for CME Group's stock. Their forecasts range from $152.00 to $227.00. On average, they anticipate CME Group's stock price to reach $192.53 in the next year. This suggests a possible upside of 17.0% from the stock's current price. View analysts' price targets for CME Group.

Has CME Group been receiving favorable news coverage?

Media headlines about CME stock have been trending neutral this week, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. CME Group earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned news headlines about the financial services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about CME Group.

Are investors shorting CME Group?

CME Group saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 5,480,000 shares, a drop of 6.6% from the May 31st total of 5,870,000 shares. Based on an average daily volume of 2,400,000 shares, the short-interest ratio is presently 2.3 days. Approximately 1.6% of the shares of the company are short sold. View CME Group's Current Options Chain.

Who are some of CME Group's key competitors?

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Walt Disney (DIS), Boeing (BA), Mastercard (MA), Visa (V), Alibaba Group (BABA), Paypal (PYPL), Cisco Systems (CSCO), Intel (INTC) and Netflix (NFLX).

Who are CME Group's key executives?

CME Group's management team includes the following people:
  • Mr. Terrence A. Duffy, Chairman & CEO (Age 61)
  • Mr. Bryan Thomas Durkin, Pres (Age 58)
  • Mr. John W. Pietrowicz M.B.A., CPA, Sr. MD & CFO (Age 54)
  • Ms. Julie Holzrichter, Sr. MD & COO (Age 50)
  • Mr. Sean P. Tully, Sr. MD and Global Head of Financial & OTC Products (Age 55)

What is CME Group's stock symbol?

CME Group trades on the NASDAQ under the ticker symbol "CME."

Who are CME Group's major shareholders?

CME Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include Manning & Napier Group LLC (0.10%), Envestnet Asset Management Inc. (0.07%), State of Alaska Department of Revenue (0.03%), Cypress Capital Group (0.02%), Gradient Investments LLC (0.01%) and DNB Asset Management AS (0.01%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy S Bitsberger and William R Shepard. View institutional ownership trends for CME Group.

Which major investors are selling CME Group stock?

CME stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., DNB Asset Management AS, Cypress Capital Group, Thomasville National Bank, Orrstown Financial Services Inc., Farmers & Merchants Trust Co of Chambersburg PA, Vigilant Capital Management LLC, and Exane Derivatives. Company insiders that have sold CME Group company stock in the last year include Daniel R Glickman, Dennis Suskind, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy, and Timothy S Bitsberger. View insider buying and selling activity for CME Group.

Which major investors are buying CME Group stock?

CME stock was bought by a variety of institutional investors in the last quarter, including Whittier Trust Co., Park National Corp OH, State of Alaska Department of Revenue, Whittier Trust Co. of Nevada Inc., Platte River Wealth Advisors LLC, Independence Bank of Kentucky, Canandaigua National Corp, and Symphony Financial Ltd. Co.. View insider buying and selling activity for CME Group.

How do I buy shares of CME Group?

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CME Group's stock price today?

One share of CME stock can currently be purchased for approximately $164.59.

How big of a company is CME Group?

CME Group has a market capitalization of $59.02 billion and generates $4.87 billion in revenue each year. The financial services provider earns $2.12 billion in net income (profit) each year or $6.80 on an earnings per share basis. CME Group employs 4,360 workers across the globe.

What is CME Group's official website?

The official website for CME Group is www.cmegroup.com.

How can I contact CME Group?

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.